XYMOGEN Ossopan MD product packaging

Image: NIH Office of Dietary Supplements, Dietary Supplement Label DatabaseNo separate image reuse license stated

XYMOGEN

Ossopan MD

Capsule

Serving size2 Capsule(s)
Servings per containerNot listed
Package240 Vegetarian Capsule(s)
Data retrievedJul 28, 2026

Checking your goal…

Checking with your list…

1 labeled serving/day preview
Open the complete check →

Supplement Facts

Serving size 2 Capsule(s)

Vitamin D2.5 mcg13% DV
Calcium400 mg31% DV
Phosphorus90 mg7% DV
Magnesium100 mg24% DV
Microcrystalline Hydroxyapatite Concentrate1 gDV not established
Microcrystalline Hydroxyapatite600 mgDV not established

Other ingredients

Hypromellose; Water; Microcrystalline Cellulose; Stearic Acid (C18:0); Medium Chain Triglyceride Oil (MCT Oil); Magnesium Stearate (Mg Stearate); Silica

Label directions

Directions: Take 2 capsules with meals; twice daily; or use as directed by your healthcare professional.

Label warnings

Consult your healthcare professional prior to use. Do not use if tamper seal is damaged. Warning: Risk of reproductive harm from exposure to lead. See www.P65Warnings.ca.gov Individuals taking medication should discuss potential interactions with their healthcare professional. Storage: Keep closed in a cool dry place out of reach of children.

Identity and label version

NIH label record335540
Entered into NIH DSLDSep 25, 2025
UPC / GTIN00871149002305
Manufacturer / distributor on labelXYMOGEN Professional Formulas
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.

NIH label history (1)

Current labelNIH record 335540Entered Sep 25, 2025
Serving size2 Capsule(s)
Formula versionc3fb063e
Ingredients on label6
NIH sourceOpen label ↗
Vitamin D2.5 mcg
Calcium400 mg
Phosphorus90 mg
Magnesium100 mg
Microcrystalline Hydroxyapatite Concentrate1 g
Microcrystalline Hydroxyapatite600 mg

Label warning: Consult your healthcare professional prior to use. Do not use if tamper seal is damaged. Warning: Risk of reproductive harm from exposure to lead. See www.P65Warnings.ca.gov Individuals taking medication should discuss potential interactions with their healthcare professional. Storage: Keep closed in a cool dry place out of reach of children.

Sources and traceability

  • NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026
    Open source ↗

More from XYMOGEN

Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.